Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardent Health (ARDT) EBITDA: 2022-2024

Historic EBITDA for Ardent Health (ARDT) over the last 3 years, with FY2024 value amounting to -$670.1 million.

  • Ardent Health's EBITDA fell 4275.73% to -$278.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$708.2 million, marking a year-over-year increase of 1300.29%. This contributed to the annual value of -$670.1 million for FY2024, which is 2040.04% up from last year.
  • According to the latest figures from FY2024, Ardent Health's EBITDA is -$670.1 million, which was up 2040.04% from -$841.8 million recorded in FY2023.
  • Ardent Health's EBITDA's 5-year high stood at -$643.7 million during FY2022, with a 5-year trough of -$841.8 million in FY2023.
  • Over the past 3 years, Ardent Health's median EBITDA value was -$670.1 million (recorded in 2024), while the average stood at -$718.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 3077.58% in 2023, then surged by 2040.04% in 2024.
  • Annual analysis of 3 years shows Ardent Health's EBITDA stood at -$643.7 million in 2022, then plummeted by 30.78% to -$841.8 million in 2023, then grew by 20.4% to -$670.1 million in 2024.
  • Its last three reported values are -$670.1 million in FY2024, -$841.8 million for FY2023, and -$643.7 million during FY2022.